Business
The world is hungry for mRNA COVID vaccines like Pfizer’s. But we’re short of vital components – The Conversation AU
Skyrocketing demand coupled with shortages of vital components is leading to bottlenecks in the supply chain of Pfizer’s and other mRNA vaccines.
Given the AstraZeneca COVID-19 vaccine is no longer recommended for under-50s following news of very rare blood clots, Australia is looking to other vaccines to plug the gap.
Pfizers mRNA vaccine will become the mainstay of the rollout, with 40 million doses expected to arrive before years end.
But Australia isnt the only country eager to get its hand on this vaccine.
Skyrocketing demand coupled with shortages of vital components is leading to bottlenecks in the supply chain of this and other mRNA…
-
General21 hours agoFrom jackaroo to ‘Golden Tonsils’ radio titan: the life and career of John Laws
-
General11 hours agoAFL gives teams finishing 10th chance to win premiership through wildcard round in finals
-
General8 hours agoPrincess Anne remembers Porepunkah police officers in wreath-laying ceremony in Melbourne
-
General20 hours agoWhen the lights go out … so does everything else